Delivery Order SPE2DB25D3201-SPE2DB25FNUFA

Award Date 6/26/25
Potential Completion Date 6/27/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,398.12, is for the supply of 4566821134 Hydralazine 20 mg/ml vials. It is a firm fixed-price, delivery order contract with a completion date of January 3, 2025. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,937.25 delivery order contract is for the supply of 4563074296 - Hydralazine 20 mg/ml vial. The contract has a firm fixed price and an ultimate completion date of December 13, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,487.22 firm-fixed-price delivery order is for the supply of HYDRALAZINE 20 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of July 14, 2025 and is not a set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of hydralazine 20 mg/ml vials, a cardiovascular medication. The contract, valued at $2,796.24, was issued by the Medical Supply Chain of the Defense Logistics Agency (DLA) and has a completion date of December 13, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $1,035.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566616068 - HYDRALAZINE 20 MG/ML VIAL. The award is a Firm Fixed Price Delivery Order contract with a completion date of December 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products...
This federal contract award is a delivery order (SPE2DB20D3103|SPE2DB25FL6E6) from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4566406249 - Hydralazine 20 mg/ml vial/ml. The $6,809.93 firm fixed-price contract has a completion date of November 13, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation. This award is part of a larger $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Hydromorphone 1 mg/ml, a pain management medication, with a ceiling value of $2,705.56 and a period of performance through May 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of hydromorphone 1 mg/ml carpujctml. The contract has a firm fixed price of $1,998.74 and a period of performance through July 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which enables the company to supply a wide range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Hydromorphone HCL ER 12 MG tablets in 100-count bottles. The contract has a fixed price of $4,192.08 and a completion date of June 11, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Hydromorphone 2 mg/ml vials. The contract, with a ceiling value of $2,145.84, is a firm fixed-price delivery order with a period of performance through September 30, 2024. AmerisourceBergen is a large pharmaceutical distributor that holds several indefinite delivery contracts with federal agencies, including a $999,999,999 contract with the DLA Troop Support...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNUFA
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Hydralazine 20 mg/ml vials. The contract has a ceiling value of $1,327.85 and a performance period through June 27, 2025. The contract is not set aside and allows for the delivery of both brand-name and generic pharmaceutical products to support military and government healthcare needs. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is part of the company's broader efforts to supply a wide range of pharmaceutical and medical supplies to various federal agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/25/25, 11:08 AM